Category: stocks

  • Nike CEO John Donahoe is out, replaced by Elliott Hill

    Nike on Thursday announced that its CEO John Donahoe is stepping down and longtime company veteran Elliott Hill will take the helm of the sneaker giant. Donahoe, who has been Nike’s CEO since Jan. 2020, will retire from his position on Oct. 13. He will stay on as an advisor through the end of January.…

  • Anybody fully understands the relationship between openai and msft? Will msft benefit if openai becomes a profitable company?

    From the latest report in ft it seems more like msft has been taken advantage off. They don’t own anything, only some capped profits, and they can show msft the finger any time the board wants: There are also signs of strain in the group’s relationship with Microsoft, which has committed $13bn to OpenAI and…

  • Help With Understanding Options P&L

    Currently Selling Covered Calls To Ease Into Options. Im Confused When I Check My P&L And See Stocks +$1100 Options -$540 My Understanding Is That I Sold Calls And Should Be Receiving Premium, Im Guessing +540 Will Be Given To Me Once The Option Is Executed Or Expired. A example For One Of My Current…

  • PLTR index inclusion – easy 9% upside?

    Basis: https://www.spglobal.com/spdji/en/documents/..septembershuffle546.pdf Please correct/ comment on plain math below. PLTR is 82B market cap, soon to be included in SP-500 index. I don't know how many trillions are parked in this index, via funds and ETFs, but that should at least be $9T. As of 2021, this number was $5.4T https://www.axios.com/2021/07/07/sp-500-index-funds-record Today, just the top…

  • $NEP – NextEra Energy Partners

    Great write up on NEP, which has a dividend yield sitting above $13% as of today: https://finance.yahoo.com/news/nextera-energy-partners-nep-best-202315270.html Despite the market thinking they were going to cut the dividend entirely (on the basis that they cut the growth rate), they affirmed the growth rate this year (that is to say the dividend yield increased this year…

  • FedEx Slumps as Lowered Outlook Offers Economic Warning Sign

    (Bloomberg) — FedEx Corp. tumbled the most in two years after warning that its business would slow in the year ahead, an ominous sign about the direction of the US economy. The parcel giant was hurt by a pullback on priority services as customers traded down to cheaper shipping options in what Chief Executive Officer…

  • Inflation moving sustainably to 2%

    Got an economics question for you all. Sounds like Powell is satisfied with inflation moving sustainably to 2%, and was apparently (at least on the surface) so thrilled by that progress that he cut rates 0.5%. However, looking at core CPI, it appears to still be stuck above 3%. https://www.usinflationcalculator.com/inflation/united-states-core-inflation-rates/ Granted, headline CPI is more…

  • Question about publicly traded private equity companies (Apollo, KKR, Carlyle, etc.)

    When you own the stocks of these companies, do you own the entire portfolio of companies, real estate, etc. or do you just own the profits generated by the management fees? In other words, do just the private investors who are invested directly with Apollo own the returns generated by those assets, or do the…

  • A Three Mile Island nuclear reactor could restart under a new deal with Microsoft

    https://www.inquirer.com/business/energy/three-mile-island-microsoft-constellation-proposal-20240920.html Five years after a nuclear reactor at the Three Mile Island plant in central Pennsylvania closed amid financial troubles, its owner wants to bring it back online. Baltimore-based Constellation Energy Corp. said Friday that it has signed a 20-year agreement with Microsoft under which the technology company will purchase power from Three Mile Island…

  • FTC sues drug middlemen (UNH, CVS, CI) for allegedly inflating insulin prices

    https://www.cnbc.com/2024/09/20/ftc-sues-drug-middlemen-for-allegedly-inflating-insulin-prices.html The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen boost their profits while “artificially” inflating costs for patients. The suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts. All are owned by…